|
Abraham E (2003). Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 187: 364-9.
Ahmed ST, Ivashkiv LB (2000). Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J Immunol 165: 5227-37.
Ahmed ST, Mayer A, Ji JD, Ivashkiv LB (2002). Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis. J Leukoc Biol 72: 154-62.
Akira S, Kishimoto T (1997). NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol 65: 1-46.
Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990). A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9: 1897-1906.
Arweiler NB, Pergola G, Kuenz J, Hellwig E, Sculean A, Auschill TM (2011). Clinical and antibacterial effect of an anti-inflammatory toothpaste formulation with Scutellaria baicalensis extract on experimental gingivitis. Clin Oral Investig 15: 909-13.
Betts JC, Cheshire JK, Akira S, Kishimoto T, Woo P (1993). The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J Biol Chem 268: 25624-31.
Cao Z, Umek RM, McKnight SL (1991). Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5: 1538-52.
Chang WH, Chen CH, Lu FJ (2002). Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines. Planta Med 68: 128-32.
Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN (1999). Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 163: 1521-8.
Chi YS, Lim H, Park H, Kim HP (2003). Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 66: 1271-8.
Cho J, Lee HK (2004). Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur J Pharmacol 485: 105-10.
Choi J, Conrad CC, Malakowsky CA, Talent JM, Yuan CS, Gracy RW (2002). Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines. Biochim Biophys Acta 1571: 201-10.
Chou TC, Chang LP, Li CY, Wong CS, Yang SP (2003). The anti-inflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth Analg 97: 1724-9.
Connolly M, Veale DJ, Fearon U (2011). Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. Ann Rheum Dis 70: 1296-1303.
Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, FitzGerald O, Poole AR, Bresnihan B, Veale DJ, Fearon U (2012). Acute-phase serum amyloid A regulates tumor necrosis factor alpha and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy. Arthritis Rheum 64: 1035-45.
Cosentino F, Assenza GE (2004). Diabetes and inflammation. Herz 29: 749-59.
Cunnane G (2001). Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol 13: 67-73.
Darnell JE Jr, Kerr IM, Stark GR (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-21.
De Beer FC, Mallya RK, Fagan EA, Lanham JG, Hughes GR, Pepys MB (1982). Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 2: 231-4.
Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, Ludwig S, Wirth T (2001). Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 276: 28451-8.
Eklund KK, Niemi K, Kovanen PT (2012). Immune functions of serum amyloid A. Crit Rev Immunol 32: 335-48.
Enomoto R, Koshiba C, Suzuki C, Lee E (2011). Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. Cancer Chemother Pharmacol 67: 1063-72.
Feldmann M, Brennan FM, Maini RN (1996). Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14: 397-440.
Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G (1989). Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 8: 3773-9.
Gao Z, Huang K, Xu H (2001). Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res 43: 173-8.
Gao Z, Huang K, Yang X, Xu H (1999). Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1472: 643-50.
Gertz MA, Kyle RA (1991). Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70: 246-56.
Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001). Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358: 24-9.
Greenstein AJ, Sachar DB, Panday AK, Dikman SH, Meyers S, Heimann T, Gumaste V, Werther JL, Janowitz HD (1992). Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine 71: 261-70.
Hagihara K, Kagawa S, Kishida Y, Arimitsu J (2013). Anti-Cytokine Therapy for AA Amyloidosis. In: Feng D (ed). Amyloidosis, edn: InTech. pp.131-52.
Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K (2004). IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun 314: 363-9.
Hagihara K, Nishikawa T, Sugamata Y, Song J, Isobe T, Taga T, Yoshizaki K (2005). Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells 10: 1051-63.
Hattori S (1930). Spectrography of the flavone series. III. The constitution of wogonin. Acta Phytochim 5: 99-116.
Hazenberg BP, van Rijswijk MH (1994). Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8: 661-90.
Hazenberg BP, van Rijswijk MH (2000). Where has secondary amyloid gone? Ann Rheum Dis 59: 577-9.
Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20.
Hou YC, Lin SP, Tsai SY, Ko MH, Chang YC, Chao PD (2011). Flavonoid pharmacokinetics and tissue distribution after repeated dosing of the roots of Scutellaria baicalensis in rats. Planta Med 77: 455-60.
Hsu W, Kerppola TK, Chen PL, Curran T, Chen-Kiang S (1994). Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol Cell Biol 14: 268-76.
Hu JZ, Bai L, Chen DG, Xu QT, Southerland WM (2010). Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang Powder. Interdiscip Sci 2: 151-6.
Hua S, Song C, Geczy CL, Freedman SB, Witting PK (2009). A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis. Redox Rep 14: 187-96.
Huang RL, Chen CC, Huang HL, Chang CG, Chen CF, Chang C, Hsieh MT (2000). Anti-hepatitis B virus effects of wogonin isolated from Scutellaria baicalensis. Planta Med 66: 694-8.
Husby G (1985). Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 3: 173-80.
Ihle JN (1995). The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol 60: 1-35.
Jensen LE, Whitehead AS (1998). Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 334: 489-503.
Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE; National Heart, Lung, and Blood Institute (2004). Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women. Circulation 109: 726-32.
Johnson GL, Lapadat R (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-2.
Kluve-Beckerman B, Drumm ML, Benson MD (1991). Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 10: 651-61.
Krakauer T, Li BQ, Young HA (2001). The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines. FEBS Lett 500: 52-5.
Kuroda T, Wada Y, Nakano M (2013). Diagnosis and Treatment of AA Amyloidosis with Rheumatoid Arthritis- State of the Art. In: Feng D (ed). Amyloidosis, edn: InTech. pp.43-62.
Kushner I (1988). The acute phase response: an overview. Methods Enzymol 163: 373-83.
Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN (2007). Natural history and outcome in systemic AA amyloidosis. N Engl J Med 256: 2361-71.
Lam TL, Lam ML, Au TK, Ip DT, Ng TB, Fong WP, Wan DC (2000). A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. Life Sci 67: 2889-96.
Lavatelli F, Vrana JA (2011). Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid 18: 177-82.
Lebel E, Vallières L, Rivest S (2000). Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges. Endocrinology 141: 3749-63.
Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, Cho GJ, Choi WS, Suk K (2003). Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 17: 1943-4.
Lee YH, Pratley RE (2005). The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5: 70-5.
Li X, Vradii D, Gutierrez S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Javed A (2005). Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1. J Cell Biochem. 96: 795-809.
Liepnieks JJ, Kluve-Beckerman B, Benson MD (1995). Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta 1270: 81-6.
Lin L, Wu XD, Davey AK, Wang J (2010). The anti-inflammatory effect of baicalin on hypoxia/reoxygenation and TNF-alpha induced injury in cultural rat cardiomyocytes. Phytother Res 24: 429-37.
Ling PR, Smith RJ, Kie S, Boyce P, Bistrian BR (2004). Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol 287: 801-8.
Ma SC, Du J, But PP, Deng XL, Zhang YW, Ooi VE, Xu HX, Lee SH, Lee SF (2002). Antiviral Chinese medicinal herbs against respiratory syncytial
virus. J Ethnopharmacol 79: 205-11.
Maini RN, Taylor PC (2000). Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 51: 207-29.
Malle E, Beer FCD (1996). Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26: 427-35.
Marhaug G (1983). Three assays for the characterization and quantitation of human serum amyloid A. Scand J Immunol 18: 329-38.
Maury CP (1984). Reactive (secondary) amyloidosis and its pathogenesis. Rheumatol Int 5: 1-7.
May MJ, Ghosh S (1982). Signal transduction through NF-kappa B. Immunol Today 19: 80-8.
May MJ, Ghosh S (1997). Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 8: 63-73.
Mielke K, Brecht S, Dorst A, Herdegen T (1999). Activity and expression of JNK1, p38 and ERK kinases, c-Jun N-terminal phosphorylation, and c-jun promoter binding in the adult rat brain following kainate-induced seizures. Neuroscience 91: 471-83.
Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K (1998). Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 78: 535-9.
Missen GA, Taylor JD (1956). Amyloidosis in rheumatoid arthritis. J Pathol Bacteriol 71: 179-92.
Miyamoto K, Katsuragi T, Abdu P, Furukawa T (1997). Effects of baicalein on prostanoid generation from the lung and contractile responses of the trachea in guinea pig. Am J Chin Med 25: 37-50.
Moshage HJ, Roelofs HM, van Pelt JF, Hazenberg BP, van Leeuwen MA, Limburg PC, Aarden LA, Yap SH (1988). The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 155: 112-7.
Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M (1999). Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 38: 499-503.
Nagai T, Suzuki Y, Tomimori T, Yamada H (1995). Antiviral activity of plant flavonoid, 5,7,4'-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses. Biol Pharm Bull 18: 295-9.
Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S (2007). Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol 25: 518-22.
Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, Worthy G, Landewé R, Smolen JS, Emery P, Buch MH (2010). Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 69: 976-86.
Ndumele CE, Pradhan AD, Ridker PM (2006). Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab Syndr 1: 190-6.
Nishida S, Hagihara K, Shima Y, Kawai M, Kuwahara Y, Arimitsu J, Hirano T, Narazaki M, Ogata A, Yoshizaki K, Kawase I, Kishimoto T, Tanaka T (2009). Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment. Ann Rheum Dis 68: 1235-6.
Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T (2004). Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 50: 1761-9.
O'Brien KD, Chait A (2006). Serum Amyloid A: The “Other” Inflammatory Protein. Curr Atheroscler Rep 8: 62-8.
Oeckinghaus A, Ghosh S (2009). The NF-κB Family of Transcription Factors and Its Regulation. Cold Spring Harb Perspect Biol 1: a000034.
Oelgeschläger M, Nuchprayoon I, Lüscher B, Friedman AD (1996). C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 16: 4717-25.
Ozawa Y, Kurihara T, Tsubota K, Okano H (2011). Regulation of Posttranscriptional Modification as a Possible Therapeutic Approach for Retinal Neuroprotection. J Ophthalmol 2011: 1-8.
Park BK, Heo MY, Park H, Kim HP (2001). Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix. Eur J Pharmacol 425: 153-7.
Pepys MB (2006). Amyloidosis. Annu Rev Med 57: 223-41.
Petersen HH, Nielsen JP, Heegaard PM (2004). Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res 35: 163-87.
Pettersson T, Konttinen YT, Maury CP (2008). Treatment strategies for amyloid A amyloidosis. Expert Opin Pharmacother 9: 2117-28.
Poli V (1998). The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions. J Biol Chem 273: 29279-82.
Röcken C, Shakespeare A (2002). Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440: 111-22.
Ramji DP, Foka P (2002). CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-75.
Roos AB, Nord M (2012). The emerging role of C/EBPs in glucocorticoid signaling: lessons from the lung. J Endocrinol 212: 291-305.
Rosenthal CJ, Franklin EC, Frangione B, Greenspan J (1976). Isolation and partial characterization of SAA-an amyloid-related protein from human serum. J Immunol 116: 1415-8.
Sellar GC, Oghene K, Boyle S, Bickmore WA, Whitehead AS (1994). Organization of the region encompassing the human serum amyloid A (SAA) gene family on chromosome 11p15.1. Genomics 23: 492-5.
Sharma S, Ghosh S, Singh LK, Sarkar A, Malhotra R, Garg OP, Singh Y, Sharma RS, Bhakuni DS, Das TK, Biswas S (2014). Identification of autoantibodies against transthyretin for the screening and diagnosis of rheumatoid arthritis. PLoS One 9: e93905.
Shirahama T, Cohen AS (1967). High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol 33: 679-708.
Shuai K, Liu B (2003). Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3: 900-11.
Sipe JD, Benson MD, Buxbaum JN, Ikeda S-i, Merlini G, Saraiva MJ, Westermark P; Nomenclature Committee of the International Society of Amyloidosis (2012). Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 19: 167-70.
Song L, Li Y, Shen B (2000). Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007. Zhonghua Xue Ye Xue Za Zhi 21: 569-71.
Steel DM, Whitehead AS (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15: 81-8.
Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP (1999). New insights into the biology of the acute phase response. J Clin Immunol 19: 203-14.
Takahashi J (1891). 漢藥黄芩之實驗説. Yakugaku Zasshi. 109: 205-9.
Tousoulis D, Charakida M, Stefanadis C (2006). Endothelial function and inflammation in coronary artery disease. Heart 92: 441-4.
Uhlar CM, Whitehead AS (1999). Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265: 501-23.
Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS (1994). Evloution of the serum amyloid A (SAA) protein superfamily. Genomics 19: 228-35.
Uhlar CM, Grehan S, Steel DM, Steinkasserer A, Whitehead AS (1997). Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators:differential kinetics of SAA2 promoter induction by IL-1β and TNF-α compared to IL-6. J Immunol Methods 203: 123-30.
Urieli-Shoval S, Shubinsky G, Linke RP, Fridkin M, Tabi I, Matzner Y (2002). Adhesion of human platelets to serum amyloid A. Blood 99: 1224-9.
Vallejo M, Ron D, Miller CP, Habener JF (1993). C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci U S A 90: 4679-83.
Wang C, Chen H, Luo H, Zhu L, Zhao Y, Tian H, Wang R, Shang P, Zhao Y (2015). Microgravity activates p38 MAPK-C/EBPβ pathway to regulate the expression of arginase and inflammatory cytokines in macrophages. Inflamm Res 64: 303-11.
Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z (2004). Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 74: 2467-78.
Wellen KE, Hotamisligil GS (2005). Inflammation, stress and diabetes. J Clin Invest 115: 1111-9.
Wu J, Attele A, Zhang L, Yuan C (2001). Anti-HIV activity of medicinal herbs:usage and potential development. Am J Chin Med 29: 69-81.
Xu G, Dou J, Zhang L, Guo Q, Zhou C (2010). Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol Pharm Bull 33: 238-43.
Yang Z, Zhu X, Guo C, Sun K (2009). Stimulation of 11β-HSD1 expression by IL-1β via a C/EBP binding site in human fetal lung fibroblasts. Endocrine 36: 404-11.
Yoshizaki K (2011). Pathogenic Role of IL-6 Combined with TNF-α or IL-1 in the Induction of Acute Phase Proteins SAA and CRP in Chronic Inflammatory Diseases. Adv Exp Med Biol 691: 141-50.
Zahedi K, Gonnerman WA, Debeer FC, Debeer MC, Steel DM, Sipe JD, Whitehead AS (1991). Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains. Inflammation 15: 1-14.
Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W, Wei H, Sung M, Wang W, Li X (2003). Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 63: 4037-43.
行政院衛生署中醫藥委員會 (2013)。臺灣中藥典 (頁254-5)。臺北市：行政院衛生署。
邱怡昌、林祐新、許萌芳、郭宗甫 (2012)。藥用植物黃芩之療效介紹。中華傳統獸醫學會會刊，16，117-32。
孫麗莉、范錫英、張冬紅 (2005)。黃芩微量元素的含量分析。微量元素與健康研究，22，68-70。
劉雄、高建德 (2007)。黃芩研究進展。甘肅中醫學院學報，24，46-50。
|